OA11965A - Diphosphate salt of a 4"-substituted-9-deoxo-9a-homoerythromycin derivative and its pharmaceutical composition. - Google Patents

Diphosphate salt of a 4"-substituted-9-deoxo-9a-homoerythromycin derivative and its pharmaceutical composition. Download PDF

Info

Publication number
OA11965A
OA11965A OA1200100329A OA1200100329A OA11965A OA 11965 A OA11965 A OA 11965A OA 1200100329 A OA1200100329 A OA 1200100329A OA 1200100329 A OA1200100329 A OA 1200100329A OA 11965 A OA11965 A OA 11965A
Authority
OA
OAPI
Prior art keywords
diphosphate
sait
water
ciaim
free base
Prior art date
Application number
OA1200100329A
Other languages
English (en)
Inventor
Douglas John Meldrum Allen
Robert John Rafka
Colman Brendan Ragan
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of OA11965A publication Critical patent/OA11965A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
OA1200100329A 1999-06-30 2000-06-13 Diphosphate salt of a 4"-substituted-9-deoxo-9a-homoerythromycin derivative and its pharmaceutical composition. OA11965A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14168199P 1999-06-30 1999-06-30

Publications (1)

Publication Number Publication Date
OA11965A true OA11965A (en) 2006-04-12

Family

ID=22496734

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200100329A OA11965A (en) 1999-06-30 2000-06-13 Diphosphate salt of a 4"-substituted-9-deoxo-9a-homoerythromycin derivative and its pharmaceutical composition.

Country Status (42)

Country Link
US (3) US6465437B1 (cs)
EP (1) EP1189913B1 (cs)
JP (1) JP2003503506A (cs)
KR (1) KR100442508B1 (cs)
CN (2) CN101220067A (cs)
AP (1) AP2001002370A0 (cs)
AR (1) AR035551A1 (cs)
AT (1) ATE286906T1 (cs)
AU (1) AU772277B2 (cs)
BG (1) BG65587B1 (cs)
BR (1) BR0012091A (cs)
CA (1) CA2376748C (cs)
CO (1) CO5190679A1 (cs)
CZ (1) CZ20014571A3 (cs)
DE (1) DE60017399T2 (cs)
EA (1) EA004235B1 (cs)
EC (1) ECSP003555A (cs)
EE (1) EE05068B1 (cs)
ES (1) ES2233380T3 (cs)
GT (2) GT200000105AA (cs)
HN (1) HN2000000090A (cs)
HR (1) HRP20010919B1 (cs)
HU (1) HUP0201693A3 (cs)
IL (1) IL146408A0 (cs)
IS (1) IS6159A (cs)
MA (1) MA26745A1 (cs)
MX (1) MXPA02000058A (cs)
MY (1) MY133360A (cs)
NO (1) NO20016221D0 (cs)
OA (1) OA11965A (cs)
PA (1) PA8496901A1 (cs)
PE (1) PE20010287A1 (cs)
PL (1) PL201891B1 (cs)
PT (1) PT1189913E (cs)
SK (1) SK286243B6 (cs)
TN (1) TNSN00143A1 (cs)
TR (1) TR200103834T2 (cs)
UA (1) UA71013C2 (cs)
UY (1) UY26221A1 (cs)
WO (1) WO2001002414A1 (cs)
YU (1) YU88701A (cs)
ZA (1) ZA200110453B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
US6791660B1 (en) * 2002-02-12 2004-09-14 Seiko Epson Corporation Method for manufacturing electrooptical device and apparatus for manufacturing the same, electrooptical device and electronic appliances
US7468428B2 (en) 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
WO2013013834A1 (en) 2011-07-27 2013-01-31 Farma Grs, D.O.O. New crystalline forms of tulathromycin
CN106008622A (zh) * 2016-08-02 2016-10-12 海门慧聚药业有限公司 泰拉霉素新晶型及其制备
CN110885351A (zh) * 2019-12-17 2020-03-17 海门慧聚药业有限公司 泰拉霉素磷酸盐的晶型及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43006B (en) * 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
SI9011409A (en) * 1990-07-18 1995-10-31 Pliva Pharm & Chem Works O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
JP2003512290A (ja) * 1997-09-10 2003-04-02 メルク エンド カムパニー インコーポレーテッド 家畜抗菌剤としての８ａ−アザライド
UA70972C2 (uk) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків
EP1189912B1 (en) * 1999-05-18 2008-04-16 Pfizer Products Inc. Novel crystalline forms of a macrolide antibiotic
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition

Also Published As

Publication number Publication date
HN2000000090A (es) 2001-04-20
PL201891B1 (pl) 2009-05-29
EP1189913B1 (en) 2005-01-12
TNSN00143A1 (fr) 2005-11-10
US20030092642A1 (en) 2003-05-15
US7297682B2 (en) 2007-11-20
EA200101178A1 (ru) 2002-06-27
EP1189913A1 (en) 2002-03-27
HUP0201693A2 (en) 2002-10-28
US6465437B1 (en) 2002-10-15
KR100442508B1 (ko) 2004-07-30
HRP20010919B1 (en) 2005-06-30
ATE286906T1 (de) 2005-01-15
JP2003503506A (ja) 2003-01-28
HRP20010919A2 (en) 2003-02-28
AP2001002370A0 (en) 2001-12-31
UA71013C2 (uk) 2004-11-15
HUP0201693A3 (en) 2003-03-28
GT200000105AA (es) 2001-12-20
AU772277B2 (en) 2004-04-22
BG106123A (en) 2002-05-31
DE60017399D1 (de) 2005-02-17
ZA200110453B (en) 2003-03-04
KR20020016875A (ko) 2002-03-06
CA2376748C (en) 2006-03-14
YU88701A (sh) 2004-09-03
PT1189913E (pt) 2005-04-29
CO5190679A1 (es) 2002-08-29
CN101220067A (zh) 2008-07-16
UY26221A1 (es) 2001-01-31
ES2233380T3 (es) 2005-06-16
EA004235B1 (ru) 2004-02-26
GT200000105A (es) 2001-12-20
PA8496901A1 (es) 2002-08-26
ECSP003555A (es) 2002-01-25
AU4943900A (en) 2001-01-22
IL146408A0 (en) 2002-07-25
NO20016221L (no) 2001-12-19
EE200100699A (et) 2003-02-17
WO2001002414A1 (en) 2001-01-11
US20040209826A1 (en) 2004-10-21
MA26745A1 (fr) 2004-12-20
CN1358188A (zh) 2002-07-10
PL352900A1 (en) 2003-09-22
IS6159A (is) 2001-11-13
AR035551A1 (es) 2004-06-16
CA2376748A1 (en) 2001-01-11
CZ20014571A3 (cs) 2002-04-17
US6861412B2 (en) 2005-03-01
NO20016221D0 (no) 2001-12-19
BG65587B1 (bg) 2009-01-30
EE05068B1 (et) 2008-08-15
PE20010287A1 (es) 2001-03-05
BR0012091A (pt) 2002-04-02
SK18922001A3 (sk) 2002-04-04
MY133360A (en) 2007-11-30
MXPA02000058A (es) 2002-07-02
DE60017399T2 (de) 2006-03-30
TR200103834T2 (tr) 2002-05-21
SK286243B6 (sk) 2008-06-06

Similar Documents

Publication Publication Date Title
DK2125850T3 (en) MACROCYCLIC POLYMORPHS, COMPOSITIONS INCLUDING SUCH POLYMORPHS, PROCEDURES FOR PREPARING AND USING THEREOF
KR100319358B1 (ko) 신규에리트로마이신 유도체, 그의 제조방법 및 의약으로서의 그의 용도
FR2727969A1 (fr) Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
OA11965A (en) Diphosphate salt of a 4"-substituted-9-deoxo-9a-homoerythromycin derivative and its pharmaceutical composition.
KR20060128633A (ko) 용매가 전혀 존재하지 않는 산 세포테탄 및 이를 수득하는방법
AU597194B2 (en) Antibacterial 9-deoxo-9a-allyl and propargyl-9a-aza-9a-homoerythromycin a derivatives
PL199434B1 (pl) Kryształ wodzianu czterosodowej soli P¹ P⁴-di(urydyno-5'-)czterofosforanu i sposób jego wytwarzania
WO1999000125A1 (en) 9a-aza-3-ketolides, compositions containing such compounds and methods of treatment
US2881163A (en) Process of preparing salts
JP2728482B2 (ja) マクロライド系抗生物質の精製法
JP2572563B2 (ja) セファロスポリン中間生成物の新規安定な結晶形
US20070021359A1 (en) Addition salts of azithromycin and citric acid and process for preparing them
SK83199A3 (en) Novel erythromycin derivatives, method of preparation and application as medicines
JPH0196190A (ja) ６−０−アルキル−エリスロマイシンａ　サイクリック１１，１２−カーボネート
EA044465B1 (ru) Способы очистки изавуконазония сульфата
WO2006064299A1 (en) Industrial process of clarithromycin associated with controlled level of side products
PL163938B1 (pl) Sposób wytwarzania uwodnionej soli sodowej kwasu 7-[2-/2-aminotiazol-4-ilo/-2-/Z/- metoksyiminoacetamido] -cefalosporanowego w postaci krystalicznej